MedTrace Logo

Efficacy and Safety of High Dose Vitamin D Supplementation for Overactive Bladder Dry in Children

NCT05709990 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 303

Last updated 2024-02-06

No results posted yet for this study

Summary

This prospective, randomized, 3-arms, parallel-design, controlled clinical trial is conducted to determine whether high dose vitamin D supplementation (combined with standard urotherapy ) improves outcomes, compared with solifenacin (combined with standard urotherapy ) ,and standard urotherapy alone in children with OAB dry.

Conditions

Interventions

DRUG

Solifenacin Succinate 5 MG Oral Tablet [Vesicare]

These patients will receive solifenacin 5-10 MG daily (combined with standard urotherapy) for 8 weeks.

DRUG

Vitamin D3

These patients will receive high dose vitamin D supplementation (more than 2000IU daily) (combined with standard urotherapy) for 8 weeks.

BEHAVIORAL

Standard urotherapy

These patients will receive standard urotherapyfor 8 weeks.

Sponsors & Collaborators

  • Xing Liu

    lead OTHER

Principal Investigators

  • Xing Liu, Doctor · Children's Hospital of Chongqing Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-15
Primary Completion
2023-06-03
Completion
2023-06-15

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05709990 on ClinicalTrials.gov